2022 was landmark year for Accrufer® and Viatris agreement sets us up for a strong 2023LikeFollowShareListen herehttps://embeds.audioboom.com/posts/8247006/embed/v4Share your feedbackQuestions (0)Post questionYour question will be visible to everyone.Start the conversationAsk Shield Therapeutics a question about this update.DiscoverShare your feedbackDiscover
